InfuSystem Holdings (INFU) Cost of Revenue (2010 - 2026)

InfuSystem Holdings (INFU) has reported Cost of Revenue for 17 consecutive years, with $15.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cost of Revenue fell 3.77% year-over-year to $15.5 million; the trailing twelve-month figure through Jun 2026 stood at $61.0 million (down 4.09% YoY), and the FY2025 full-year result was $63.1 million, down 2.04% from the prior year.
• Cost of Revenue advanced to $15.5 million in Q2 2026 per INFU's latest filing, from $14.0 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $17.0 million in Q2 2024 and bottomed at $11.1 million in Q3 2022.
• Historically, Cost of Revenue has averaged $15.0 million across 5 years, with a median of $15.5 million in 2024.
• The sharpest annual moves came in 2023 and 2026: Cost of Revenue jumped 47.31% in 2023, then slipped 9.95% in 2026.
• Over 5 years, Cost of Revenue stood at $14.8 million in 2022, then advanced by 2.05% to $15.1 million in 2023, then increased by 3.8% to $15.6 million in 2024, then increased by 1.04% to $15.8 million in 2025, then slipped by 1.74% to $15.5 million in 2026.
• According to Business Quant data, Cost of Revenue over the past three periods registered $15.5 million, $14.0 million, and $15.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.